title: Anaphylactoid reactions during dextran apheresis may occur even in the absence of ACE-inhibitor administration.
authors.forename: A
authors.initials: A
authors.lastname: Schwarzbeck
authors.forename: U
authors.initials: U
authors.lastname: Hilgenfeldt
authors.forename: U
authors.initials: U
authors.lastname: Riester
authors.forename: M
authors.initials: M
authors.lastname: Rambausek
authors.forename: A
authors.initials: A
authors.lastname: Kiral
mesh_terms: D000328:Adult; D000707:Anaphylaxis / Q000097:blood / Q000209:etiology*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D001781:Blood Component Removal / Q000009:adverse effects*; D001920:Bradykinin / Q000097:blood; D003911:Dextrans; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000628:therapy
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D003911:Dextrans; D001920:Bradykinin